Avadel Pharmaceuticals plc 2024 Q4 – Results – Earnings Call Presentation #Avadel #Pharmaceuticals #plc #Results #Earnings…
Tag: Pharmaceuticals
Vertex Pharmaceuticals Incorporated (VRTX) TD Cowen 45th Annual Health Care Conference (Transcript)
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) TD Cowen 45th Annual Health Care Conference Transcript March 3, 2025 3:10…
Apellis Pharmaceuticals, Inc. (APLS) Q4 2024 Earnings Call Transcript
Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) Q4 2024 Earnings Conference Call February 28, 2025 8:30 AM ET Company…
Apellis Pharmaceuticals, Inc. 2024 Q4 – Results – Earnings Call Presentation
Apellis Pharmaceuticals, Inc. 2024 Q4 – Results – Earnings Call Presentation #Apellis #Pharmaceuticals #Results #Earnings #Call…
Hikma Pharmaceuticals PLC (HKMPF) Q4 2024 Earnings Call Pre-Recorded (Transcript)
Hikma Pharmaceuticals PLC (OTCPK:HKMPF) Q4 2024 Results Conference Call February 26, 2025 2:00 AM ET Company…
Supernus Pharmaceuticals, Inc. (SUPN) Q4 2024 Earnings Call Transcript
Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Q4 2024 Earnings Conference Call February 25, 2025 4:30 PM ET Company…
BioCryst Pharmaceuticals, Inc. 2024 Q4 – Results – Earnings Call Presentation (NASDAQ:BCRX)
This article was written by Follow Seeking Alpha’s transcripts team is responsible for the development of…
Aurinia Pharmaceuticals: There's Still Time For Sales Growth
Aurinia Pharmaceuticals: There's Still Time For Sales Growth #Aurinia #Pharmaceuticals #There039s #Time #Sales #Growth
Universe Pharmaceuticals stock plunges to 52-week low of $0.14
Universe Pharmaceuticals stock plunges to 52-week low of $0.14#Universe #Pharmaceuticals #stock #plunges #52week
The Rise of Recursion Pharmaceuticals: A Biotech Stock on the Move
As I scan the market, one stock that’s caught my attention is Recursion Pharmaceuticals Inc. (NASDAQ:RXRX).…
Olema Pharmaceuticals: Interesting But Undifferentiated Data
Olema Pharmaceuticals: Interesting But Undifferentiated Data #Olema #Pharmaceuticals #Interesting #Undifferentiated #Data
Terns Pharmaceuticals stock hits 52-week low at $4.16
Terns Pharmaceuticals stock hits 52-week low at $4.16#Terns #Pharmaceuticals #stock #hits #52week
Supernus Pharmaceuticals to Host Conference Call and Webcast on February 25, 2025, to Discuss Fourth Quarter and Full Year 2024 Financial Results
Supernus Pharmaceuticals to Host Conference Call and Webcast on February 25, 2025, to Discuss Fourth Quarter…
Arrowhead Pharmaceuticals, Inc. (ARWR) Q1 2025 Earnings Call Transcript
Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) Q1 2025 Earnings Conference Call February 10, 2025 4:30 PM ET Company…
Vertex Pharmaceuticals Incorporated (VRTX) Q4 2024 Earnings Call Transcript
Vertex Pharmaceuticals Incorporated (VRTX) Q4 2024 Earnings Call Transcript #Vertex #Pharmaceuticals #Incorporated #VRTX #Earnings #Call #Transcript
Foresee Pharmaceuticals Announces Acceptance of An Abstract for Presentation at ASCO Genitourinary Cancers Symposium 2025
Foresee Pharmaceuticals Announces Acceptance of An Abstract for Presentation at ASCO Genitourinary Cancers Symposium 2025#Foresee #Pharmaceuticals…
Fennec Pharmaceuticals director Raykov sells $66,600 in shares
Fennec Pharmaceuticals director Raykov sells $66,600 in shares#Fennec #Pharmaceuticals #director #Raykov #sells #shares
ROSEN, LEADING TRIAL ATTORNEYS, Encourages Regeneron Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – REGN
ROSEN, LEADING TRIAL ATTORNEYS, Encourages Regeneron Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in…
ROSEN, TOP-RANKED INVESTOR COUNSEL, Encourages Regeneron Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – REGN
ROSEN, TOP-RANKED INVESTOR COUNSEL, Encourages Regeneron Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in…
Looking Back On Ligand Pharmaceuticals
Looking Back On Ligand Pharmaceuticals #Ligand #Pharmaceuticals
Processa Pharmaceuticals CEO George Ng buys shares worth $69,542
Processa Pharmaceuticals CEO George Ng buys shares worth $69,542#Processa #Pharmaceuticals #CEO #George #buys #shares #worth